Category Archives: Pr Newswire

SIGA Announces U.S. Government Procurement Order of $113 Million for Oral TPOXX®

Exercise of Procurement Option under Current Contract Reflects Continuing Action to Enhance Orthopoxvirus Preparedness NEW YORK, July 19, 2024 (GLOBE NEWSWIRE) — SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today announced that the U.S. Department of Health and Human Services exercised a procurement option for the delivery of approximately $113 million of oral TPOXX® […]

4 Days of Family Fun at Cotai Expo – Free-Admission Sands Shopping Carnival Open Now

Free business platform for local SMEs and Sands retailers July 18-21 Supports Macao government’s “tourism+” initiative MACAO, July 19, 2024 /PRNewswire/ — Sands China’s annual signature event, the 2024 Sands Shopping Carnival, kicked off Thursday at The Venetian® Macao with an opening ceremony attended by representatives from the government, finance, business, and community services sectors. […]

Twelve Students from KIIT-DU Qualify for Paris Olympics

KIIT-KISS Founder announces Rs 7 lakh to each of the athletes  BHUBANESWAR, India, July 19, 2024 /PRNewswire/ — In a big achievement for KIIT Deemed to be University (KIIT-DU), Bhubaneswar, 12 students have successfully qualified for the Paris Olympics 2024 beginning July 26, bringing pride and joy to the institution. KIIT-KISS Dr Achyuta Samanta (third from […]

KraneShares Launches AGIX: An Artificial Intelligence & Technology ETF That Provides Investors Exposure to Companies Across the AI Ecosystem

NEW YORK, July 19, 2024 /PRNewswire/ — Krane Funds Advisors, LLC (“KraneShares”), an asset management firm known for its global exchange-traded funds (ETFs), launched the KraneShares Artificial Intelligence & Technology ETF (Ticker: AGIX) on the Nasdaq Stock Market (NASDAQ) on July 18th, 2024. AGIX tracks the Solactive Etna Artificial General Intelligence Index, which is designed […]

Baseus posts strong 2024 H1 sales on Amazon Japan with new flagship products

TOKYO, July 19, 2024 /PRNewswire/ — Baseus, a leading global brand of consumer electronics and mobile phone accessories, has achieved remarkable success on Amazon Japan, becoming one of the brand’s primary sales channels in the country. Baseus posted its strongest sales on the site in the first half of 2024 thanks to the high popularity […]

China Mount Taishan Tianping Lake Tourist Center Opens

TAIAN, China, July 19, 2024 /PRNewswire/ — This is a report from the Shandong Office of Hong Kong Business Daily. Recently, the opening ceremony of Mount Taishan Tianping Lake Tourist Center and the departure ceremony of the “dare to” Mount Taishan through train were held in Tai’an, Shandong Province. “When I first arrived at the tourist […]

Artiva Biotherapeutics Announces Pricing of Upsized $167.0 Million Initial Public Offering

SAN DIEGO, July 18, 2024 (GLOBE NEWSWIRE) — Artiva Biotherapeutics, Inc. (Nasdaq: ARTV), a clinical-stage biotechnology company whose mission is to develop effective, safe and accessible cell therapies for patients with devastating autoimmune diseases and cancers, today announced the pricing of its upsized initial public offering of 13,920,000 shares of common stock at a price […]

Abliva Announces Positive Interim Analysis of the FALCON Study for KL1333 in Primary Mitochondrial Disease

– Independent committee confirms FALCON study is powered for potential success with both alternative endpoints passing futility- -Committee confirms strong safety profile of KL1333- – Abliva to host conference call and webcast on Friday 19 July at 4:30 pm CET / 10:30 am ET – LUND, Sweden, July 18, 2024 (GLOBE NEWSWIRE) — Abliva AB […]

Appili Therapeutics Announces Second Amendment to Arrangement Agreement

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES HALIFAX, Nova Scotia, July 18, 2024 (GLOBE NEWSWIRE) — Appili Therapeutics Inc. (TSX: APLI; OTCPink: APLIF) (the “Company” or “Appili”), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, announces that it has entered into a […]

Serina Therapeutics Appoints Srini Tenjarla, Ph.D. as Senior Vice President of CMC and Formulation

HUNTSVILLE, AL, July 18, 2024 (GLOBE NEWSWIRE) — Serina Therapeutics, Inc. (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company developing its proprietary POZ Platform™ drug delivery technology, today announced the appointment of Dr. Srini Tenjarla as the new Senior Vice President of CMC (Chemistry, Manufacturing, and Controls) and Formulation. Dr. Tenjarla brings over 20 years of extensive […]